Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index; 72 of the 258 sources its claims cite were checked for support.

Interaction between microbiota and immunity in health and disease

Open access

Abstract

The interplay between the commensal microbiota and the mammalian immune system development and function includes multifold interactions in homeostasis and disease. The microbiome plays critical roles in the training and development of major components of the host’s innate and adaptive immune system, while the immune system orchestrates the maintenance of key features of host-microbe symbiosis. In a genetically susceptible host, imbalances in microbiota-immunity interactions under defined environmental contexts are believed to contribute to the pathogenesis of a multitude of immune-mediated disorders. Here, we review features of microbiome-immunity crosstalk and their roles in health and disease, while providing examples of molecular mechanisms orchestrating these interactions in the intestine and extra-intestinal organs. We highlight aspects of the current knowledge, challenges and limitations in achieving causal understanding of host immune-microbiome interactions, as well as their impact on immune-mediated diseases, and discuss how these insights may translate towards future development of microbiome-targeted therapeutic interventions.

Overview

CoChat Summary

TL;DR

This review synthesizes bidirectional interactions between the commensal microbiota and host innate/adaptive immunity in homeostasis and immune-mediated disease. It highlights mechanistic examples across the intestine and extra-intestinal organs while emphasizing that causal relationships and translation to microbiome-targeted therapies remain unresolved.

Key findings

  • The microbiome trains major immune components, including intraepithelial lymphocytes, IgA, Th17 cells, regulatory T cells, ILC3s, and Tfh cells; germ-free animals show profound immune defects that can be restored by colonization.
  • Host immunity maintains microbiota compartmentalization through mucus, tight junctions, secretory IgA, antimicrobial peptides, PRRs, and inflammasomes; dysregulation is implicated in IBD, rheumatoid arthritis, cardiometabolic disease, cancer, and extra-intestinal organ immunity.
  • Early-life colonization is critical, with microbiota composition reaching a more stable adult-like configuration at ~3 years of age; IBD genome-wide association studies have revealed more than 200 susceptibility loci, many involved in microbial sensing.
  • Several grams of IgA are secreted daily in human intestines, and microbiome-immune interactions can modulate anticancer immunotherapy responses, including associations with *Bifidobacterium longum*, *Collinsella aerofaciens*, *Enterococcus faecium*, and *Akkermansia muciniphila*.

Methods

  • Narrative review of published literature on microbiome-immunity crosstalk in health and disease, including animal models and human studies.
  • No primary data, cohort, or systematic search/meta-analysis is reported; the paper synthesizes mechanistic examples and conceptual frameworks.
  • Main analysis is conceptual and integrative, covering intestinal homeostasis, environmental perturbations, disease associations, extra-intestinal organs, and therapeutic perspectives.

Limitations

  • The paper states that direct causal relationships between the microbiome and immunity before or during early disease have not been established in most medical conditions, and that whether microbiome alterations are cause or consequence remains unclear in diseases such as IBD.
  • It states that laboratory mice harbor microbiota divergent from wild animals and humans, limiting translational potential and reproducibility, and that 16S rRNA sequencing is limited by genus-level, compositional resolution.
  • It also states that low-biomass microbiome studies are challenged by contamination and artefacts, and that inter-individual variability is a major experimental challenge; evident from the text, this is a narrative review without systematic methods or quantitative synthesis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41422-020-0332-7

Cites

271 of 271 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Intestinal microbiota-immunity interplay in homeostasis. Selected mechanistically well-characterized microbiota-immune system interactions are depicted. Microbiome-derived TLR and NOD ligands and metabolites (e.g., SCFA, AhR ligands) act directly on enterocytes and intestinal immune cells, but can also reach remote tissues via the systemic circulation to modulate immunity. Foxp3+ Treg cells and Tfh/ex-Th17 cells localize in Peyer’s patches to promote class switch of B cells and production of secretory (s)IgA. These contribute to compartmentalization of commensal microbiota and regulate homeostatic microbiota composition. Intestinal colonization by SFB and many other commensals promotes differentiation of CD4+ Th17 cells. Moreover, SFB colonization elicits signaling via the ILC3/IL-22/SAA1/2 axis to induce IL-17A production by RORγt+ Th17 cells. ILC3-derived IL-22 contributes to containment of specific microbiota members by promoting IL-17A production by Th17 cells. Furthermore, deletion of ILC3-expressed MHCII activates commensal-specific CD4+ T cells to prevent an immune response against harmless colonizers. Early-life microbial colonization limits the expansion of iNKT cells, in part via production of sphingolipids, to prevent potential disease-promoting activity within the intestinal lamina propria and the lungs. Colonization with Bacteroides fragilis, a prominent member of mammalian intestinal microbiota, is able to promote CD4+ T cell differentiation and to balance Th1 and Th2 populations, an effect that relies on its PSA. PSA is taken up by lamina propria DCs through a TLR2-dependent mechanism and presented to naïve CD4+ T cells. In the simultaneous presence of activated TGF-β, these cells can differentiate to regulatory T cells (iTreg). IL-10 produced by these cells promotes immune homeostasis. Contrarily, IL-23 licensed through the same cascade promotes expansion of pro-inflammatory Th17 cells.
Fig. 1 Intestinal microbiota-immunity interplay in homeostasis. Selected mechanistically well-characterized microbiota-immune system interactions are depicted. Microbiome-derived TLR and NOD ligands and metabolites (e.g., SCFA, AhR ligands) act directly on enterocytes and intestinal immune cells, but can also reach remote tissues via the systemic circulation to modulate immunity. Foxp3+ Treg cells and Tfh/ex-Th17 cells localize in Peyer’s patches to promote class switch of B cells and production of secretory (s)IgA. These contribute to compartmentalization of commensal microbiota and regulate homeostatic microbiota composition. Intestinal colonization by SFB and many other commensals promotes differentiation of CD4+ Th17 cells. Moreover, SFB colonization elicits signaling via the ILC3/IL-22/SAA1/2 axis to induce IL-17A production by RORγt+ Th17 cells. ILC3-derived IL-22 contributes to containment of specific microbiota members by promoting IL-17A production by Th17 cells. Furthermore, deletion of ILC3-expressed MHCII activates commensal-specific CD4+ T cells to prevent an immune response against harmless colonizers. Early-life microbial colonization limits the expansion of iNKT cells, in part via production of sphingolipids, to prevent potential disease-promoting activity within the intestinal lamina propria and the lungs. Colonization with Bacteroides fragilis, a prominent member of mammalian intestinal microbiota, is able to promote CD4+ T cell differentiation and to balance Th1 and Th2 populations, an effect that relies on its PSA. PSA is taken up by lamina propria DCs through a TLR2-dependent mechanism and presented to naïve CD4+ T cells. In the simultaneous presence of activated TGF-β, these cells can differentiate to regulatory T cells (iTreg). IL-10 produced by these cells promotes immune homeostasis. Contrarily, IL-23 licensed through the same cascade promotes expansion of pro-inflammatory Th17 cells.CC BY · PubMed Central
Fig. 2 Dysregulation of microbiome-immunity interaction in disease. Under the influence of certain environmental factors and host genetic susceptibility, aberrant interactions between the microbiome and the host’s immune system contribute to the development of various immune-mediated disorders. In IBD as an example, antibiotic use or dietary changes, in the presence of genetic susceptibility (e.g., NOD2 mutation), may lead to alterations of the gut microbiome configuration, including decreased richness and perturbed taxonomic and metabolite composition. These microbiome alterations are strongly associated with aberrant mucosal immune responses, including upregulated Th17, Th1 and Th2 type responses, downregulated T regulatory cells, and dysregulated humoral immunity. This may finally result in chronic, clinically-overt intestinal inflammation and tissue injury.
Fig. 2 Dysregulation of microbiome-immunity interaction in disease. Under the influence of certain environmental factors and host genetic susceptibility, aberrant interactions between the microbiome and the host’s immune system contribute to the development of various immune-mediated disorders. In IBD as an example, antibiotic use or dietary changes, in the presence of genetic susceptibility (e.g., NOD2 mutation), may lead to alterations of the gut microbiome configuration, including decreased richness and perturbed taxonomic and metabolite composition. These microbiome alterations are strongly associated with aberrant mucosal immune responses, including upregulated Th17, Th1 and Th2 type responses, downregulated T regulatory cells, and dysregulated humoral immunity. This may finally result in chronic, clinically-overt intestinal inflammation and tissue injury.CC BY · PubMed Central
Fig. 3 Microbiome-immunity interaction in extra-intestinal organs. The gut microbiome and microbiome-associated metabolites translocate from the intestinal lumen to various organs (e.g., liver, brain or lung) through the circulatory system, and subsequently induce tissue-specific local immune responses. In the liver, bacterial LPS is recognized by TLR4 in different cell types, leading to upregulation of various pro-inflammatory chemokines and adhesion molecules. MAMPs influence the number, function and maturation of Kupffer cells, and glycolipid antigen-containing probiotics can activate hepatic NKT cells. The gut-resident pathobiont Klebsiella pneumoniae can translocate and induce Th17 cell responses in the liver. In the CNS, microbiome-derived SCFAs regulate microglial homeostasis, and promote regulatory T cells to counter-regulate CNS autoimmunity. In the lung, SCFA-induced primed myeloid cells translocate to the lung and shape the pulmonary immunological landscape. Clostridium orbiscindens-derived product desaminotyrosine modulates type I IFN signaling. In addition, exposure to different lung-resident microbes (e.g., Pseudomonas, Lactobacillus, pneumotypeSPT) is associated with an enhanced Th17 type response.
Fig. 3 Microbiome-immunity interaction in extra-intestinal organs. The gut microbiome and microbiome-associated metabolites translocate from the intestinal lumen to various organs (e.g., liver, brain or lung) through the circulatory system, and subsequently induce tissue-specific local immune responses. In the liver, bacterial LPS is recognized by TLR4 in different cell types, leading to upregulation of various pro-inflammatory chemokines and adhesion molecules. MAMPs influence the number, function and maturation of Kupffer cells, and glycolipid antigen-containing probiotics can activate hepatic NKT cells. The gut-resident pathobiont Klebsiella pneumoniae can translocate and induce Th17 cell responses in the liver. In the CNS, microbiome-derived SCFAs regulate microglial homeostasis, and promote regulatory T cells to counter-regulate CNS autoimmunity. In the lung, SCFA-induced primed myeloid cells translocate to the lung and shape the pulmonary immunological landscape. Clostridium orbiscindens-derived product desaminotyrosine modulates type I IFN signaling. In addition, exposure to different lung-resident microbes (e.g., Pseudomonas, Lactobacillus, pneumotypeSPT) is associated with an enhanced Th17 type response.CC BY · PubMed Central

Verification

Claims the paper makes

58 Valid · 3 Not valid · 152 Not checked · 13 Own results and interpretations

158 more claims · 42 with their cited sources checked

Create a free account to see all 226 claims and to verify the 186 references still open.

See all claims — free account
  • It may state two separate claims as one. 55
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 271 references

Cited by

See all 3,947

Metadata

Authors
Zheng, D., Liwinski, T., & Elinav, E.
Affiliations
  • Sun Yat-sen University (CN)
  • University Medical Center Hamburg-Eppendorf (DE)
  • German Cancer Research Center (DE)
Corresponding author
Elinav, Eran
Venue
Cell Research
Published
2020-05-20
Volume
30
Issue
6
Pages
492-506
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W3027658010
Cited by
3,947
References
271
Citations by year
2026: 594 · 2025: 817 · 2024: 858 · 2023: 630 · 2022: 585 · 2021: 397 · 2020: 61
FWCI
39.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • Bill and Melinda Gates Foundation
  • Canadian Institute for Advanced Research
  • Deutsche Forschungsgemeinschaft (420943353)
  • Sun Yat-sen University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
microbiota-immune interactions, gut microbiota, innate immunity, adaptive immunity, immune system development, host-microbe symbiosis, immune-mediated diseases, intestinal immunity, microbiome-targeted therapy, immune homeostasis
MeSH terms
Gastrointestinal Microbiome, Animals, Homeostasis, Humans, Immunity, Innate, Intestinal Mucosa, Symbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction between microbiota and immunity in health and disease. https://app.cochat.ai/papers/10.1038/s41422-020-0332-7
The paper
Zheng, D., Liwinski, T., & Elinav, E. (2020). Interaction between microbiota and immunity in health and disease. Cell Research. https://doi.org/10.1038/s41422-020-0332-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.